Antares Pharma, Inc. (ATRS) said Tuesday that it has closed its firm commitment underwritten public offering of 12.5 million shares of the company's common stock at a purchase price of $4.00 per share.
The net proceeds to the company are expected to be about $46.7 million, after deducting underwriting commissions and estimated offering expenses payable by the company.
Jefferies & Company, Inc. and Oppenheimer and Co. Inc. acted as joint book-running managers for the offering. Cowen and Company, LLC and Ladenburg Thalmann & Co. Inc. acted as co-managers for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.